205 related articles for article (PubMed ID: 36002036)
21. Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.
Peluso G; Tian E; Abusleme L; Munemasa T; Mukaibo T; Ten Hagen KG
J Biol Chem; 2020 Jan; 295(5):1411-1425. PubMed ID: 31882545
[TBL] [Abstract][Full Text] [Related]
22. Generation of human bronchial epithelial cell lines expressing inactive mutants of GALNT3.
Nakamura S; Horie M; Fujino K; Matsumoto Y; Honda T; Tomonaga K
J Vet Med Sci; 2012 Nov; 74(11):1493-6. PubMed ID: 22785053
[TBL] [Abstract][Full Text] [Related]
23. The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation.
Herbomel GG; Rojas RE; Tran DT; Ajinkya M; Beck L; Tabak LA
PLoS One; 2017; 12(7):e0179241. PubMed ID: 28719662
[TBL] [Abstract][Full Text] [Related]
24. Mucin-type O-glycosylation and its potential use in drug and vaccine development.
Tarp MA; Clausen H
Biochim Biophys Acta; 2008 Mar; 1780(3):546-63. PubMed ID: 17988798
[TBL] [Abstract][Full Text] [Related]
25. A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation.
Clausen H; Bennett EP
Glycobiology; 1996 Sep; 6(6):635-46. PubMed ID: 8922959
[No Abstract] [Full Text] [Related]
26. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
[TBL] [Abstract][Full Text] [Related]
27. Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates.
Brockhausen I; Toki D; Brockhausen J; Peters S; Bielfeldt T; Kleen A; Paulsen H; Meldal M; Hagen F; Tabak LA
Glycoconj J; 1996 Oct; 13(5):849-56. PubMed ID: 8910012
[TBL] [Abstract][Full Text] [Related]
28. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
29. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Wang ZQ; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Bachvarov D
Oncotarget; 2014 Jan; 5(2):544-60. PubMed ID: 24504219
[TBL] [Abstract][Full Text] [Related]
30. Glycopeptide N-acetylgalactosaminyltransferase specificities for O-glycosylated sites on MUC5AC mucin motif peptides.
Tetaert D; Ten Hagen KG; Richet C; Boersma A; Gagnon J; Degand P
Biochem J; 2001 Jul; 357(Pt 1):313-20. PubMed ID: 11415465
[TBL] [Abstract][Full Text] [Related]
31. Loss of Neuron Navigator 2 Impairs Brain and Cerebellar Development.
Accogli A; Lu S; Musante I; Scudieri P; Rosenfeld JA; Severino M; Baldassari S; Iacomino M; Riva A; Balagura G; Piccolo G; Minetti C; Roberto D; Xia F; Razak R; Lawrence E; Hussein M; Chang EY; Holick M; Calì E; Aliberto E; De-Sarro R; Gambardella A; Network UD; Group SS; Emrick L; McCaffery PJA; Clagett-Dame M; Marcogliese PC; Bellen HJ; Lalani SR; Zara F; Striano P; Salpietro V
Cerebellum; 2023 Apr; 22(2):206-222. PubMed ID: 35218524
[TBL] [Abstract][Full Text] [Related]
32. The chemistry and biology of mucin-type O-linked glycosylation.
Hang HC; Bertozzi CR
Bioorg Med Chem; 2005 Sep; 13(17):5021-34. PubMed ID: 16005634
[TBL] [Abstract][Full Text] [Related]
33. High level in vivo mucin-type glycosylation in Escherichia coli.
Mueller P; Gauttam R; Raab N; Handrick R; Wahl C; Leptihn S; Zorn M; Kussmaul M; Scheffold M; Eikmanns B; Elling L; Gaisser S
Microb Cell Fact; 2018 Oct; 17(1):168. PubMed ID: 30367634
[TBL] [Abstract][Full Text] [Related]
34. Polypeptide:N-acetylgalactosaminyltransferase activities towards the mucin MUC5AC peptide motif using microsomal preparations of normal and tumoral digestive mucosa.
Hennebicq S; Tetaert D; Soudan B; Briand G; Richet C; Demeyer D; Gagnon J; Petillot Y; Degand P
Biochimie; 1998 Jan; 80(1):69-73. PubMed ID: 9587664
[TBL] [Abstract][Full Text] [Related]
35. Ethanol exposure during development reduces GABAergic/glycinergic neuron numbers and lobule volumes in the mouse cerebellar vermis.
Nirgudkar P; Taylor DH; Yanagawa Y; Valenzuela CF
Neurosci Lett; 2016 Oct; 632():86-91. PubMed ID: 27565053
[TBL] [Abstract][Full Text] [Related]
36. Purkinje cell compartmentalization in the cerebellum of the spontaneous mutant mouse dreher.
Sillitoe RV; George-Jones NA; Millen KJ; Hawkes R
Brain Struct Funct; 2014 Jan; 219(1):35-47. PubMed ID: 23160833
[TBL] [Abstract][Full Text] [Related]
37. Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome.
Yu T; Meiners LC; Danielsen K; Wong MT; Bowler T; Reinberg D; Scambler PJ; van Ravenswaaij-Arts CM; Basson MA
Elife; 2013 Dec; 2():e01305. PubMed ID: 24368733
[TBL] [Abstract][Full Text] [Related]
38. Distinct expression patterns of inwardly rectifying potassium currents in developing cerebellar granule cells of the hemispheres and the vermis.
Brandalise F; Lujan R; Leone R; Lodola F; Cesaroni V; Romano C; Gerber U; Rossi P
Eur J Neurosci; 2016 Jun; 43(11):1460-73. PubMed ID: 26921581
[TBL] [Abstract][Full Text] [Related]
39.
Zhang J; Wei K; Qu W; Wang M; Zhu Q; Dong X; Huang X; Yi W; Xu S; Li X
J Neurosci; 2023 Jun; 43(25):4559-4579. PubMed ID: 37225434
[TBL] [Abstract][Full Text] [Related]
40. Mucin-type O-glycosylation during development.
Tran DT; Ten Hagen KG
J Biol Chem; 2013 Mar; 288(10):6921-9. PubMed ID: 23329828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
